Skip to content
Stocks ended the week on modest gains, as bulls turn their attention to next week's earnings report. With that in mind, let's look at a few top stock trades for Monday. Top Stock Trades for Monday No. 1: Amazon (AMZN) Click to EnlargeSource: Chart courtesy of StockCharts.comAmazon (NASDAQ:AMZN) has been on a tear from the March lows. Even after the latest pullback, shares are still up about 80% from the lows. The stock is now down for five straight sessions and failing to hold the 10-day moving average. To be honest, this is exactly what you want to see if you are a bull in Amazon. The last thing you want ahead of earnings is a surge higher into the print. InvestorPlace - Stock Market News, Stock Advice & Trading TipsIf shares continue lower ahead of the print, see if the 20-day moving average holds as support, followed by uptrend support...
Stocks finished mixed on Friday, though all three major indices remained on track to end the week higher. The Dow ended a four-day winning streak, after new data showed a greater-than-expected number of new jobless claims were filed last week. The Final Round panel breaks down the details.
...
With millions of Americans depending on 401(k) and IRA assets for their retirement income, a market downturn can wipe out decades of investment in a single go. And while young workers at least have the time to rebuild their savings after a … Continue reading ->The post How to Retire into a Bear Market appeared first on SmartAsset Blog....
EKS Associates Senior Wealth Advisor Darren Zagarola joins The Final Round to highlight some of the most common mistakes people make in retirement planning and the importance of not being overly conservative in your investment portfolio....
While not a mind-blowing move, it is good to see that the Equitrans Midstream Corporation (NYSE:ETRN) share price has......
(Bloomberg) -- Those betting against high-flying vaccine developer Moderna Inc. have taken their lumps this year with the biotech’s 370% rally costing short sellers almost $1.5 billion, according to financial analytics firm S3 Partners.The Cambridge, Massachusetts-based biotech has boomed into a $36 billion behemoth amid excitement for its vaccine to treat the novel coronavirus. Still, even with the stock’s parabolic move this week, it’s primed for a squeeze with short investor losses potentially outweighing overbought price conviction, S3 Partners managing director Ihor Dusaniwsky said in a note.Moderna surged 6.9% to a record on Wednesday after early results from its Covid-19 vaccine candidate drew Wall Street praise. With the company set to start a final-stage study of the vaccine this month, excitement for the company and nerves for short sellers could push the stock even higher.“There is $2.4 billion of buy-to-cover dry powder in this stock, once shorts begin to cover in...
Bank of America (NYSE:BAC) reported second quarter earnings in mid-July that largely failed to impress. While the bank beat on the top and bottom lines, revenues fell 3% year-over-year, the efficiency ratio rose 3 points, pre-provision profits fell 9%, net interest income dropped 11% and net profits plunged more than 50% as the bank built its reserves in anticipation of economic volatility over the next few months.Source: Michael Vi / Shutterstock.com BAC stock fell about 2% after the print.Although Bank of America's second quarter earnings were not good, Bank of America stock is a buy on this dip, mostly because when it comes to the big bank, the future is a lot brighter than the past.InvestorPlace - Stock Market News, Stock Advice & Trading TipsHere's a deeper look. Weak Bank of America EarningsBank of America had a weak second quarter.Sure, the bank beat Wall Street's top and bottom line estimates. But...
